ARTICLE | Clinical News
Cumulase regulatory update
April 25, 2005 7:00 AM UTC
FDA granted 510(k) clearance for Cumulase, an ex vivo formulation of recombinant human PH20 hyaluronidase, to treat oocytes to facilitate certain in vitro fertilization (IVF) procedures. ...